A Pragmatic Randomized Controlled Trial of Thiopurine Methyltransferase Genotyping Prior to Azathioprine Treatment: the TARGET Study

Abstract

Our work supports the strong evidence that individuals with TPMT variant homozygosity are at high risk of severe neutropenia, whereas TPMT heterozygotes are not at increased risk of ADRs at standard doses of azathioprine.